Effects of interferon α-2b on barrier function and junctional complexes of renal proximal tubular LLC-PK1 cells  by Lechner, Judith et al.
Kidney International, Vol. 55 (1999), pp. 2178–2191
Effects of interferon a-2b on barrier function and junctional
complexes of renal proximal tubular LLC-PK1 cells
JUDITH LECHNER, MARKUS KRALL, ALEXANDRA NETZER, CHRISTIAN RADMAYR,
MICHAEL P. RYAN, and WALTER PFALLER
Institute of Physiology and Clinic of Urology, University of Innsbruck, Innsbruck, Austria; and Department of Pharmacology,
University College Dublin, Dublin, Ireland
Effects of interferon a-2b on barrier function and junctional against neoplastically transformed or virus-infected cells
complexes of renal proximal tubular LLC-PK1 cells. [4] combined with direct cytotoxicity [5]. Type I INFs
Background. Interferon a-2b (IFNa) treatment of diseases include IFNa, b, and v species. IFNg activates differentcan be accompanied by impaired renal function and capillary
intracellular signaling events by the use of a distinct setleak syndrome. To explore potential mechanisms of IFNa-
of receptors, namely type II IFN receptors [6, 7]. Recom-induced renal dysfunction, an in vitro cell culture model system
was established to investigate the effects of IFNa on barrier binant technology allowed the production of IFNa sub-
function and junctional complexes. types that are thus available for clinical usage [8].
Methods. LLC-PK1 cells were cultured on microporous Interferon a therapy is limited by the occurrence ofmembranes. Transepithelial resistance (TER) was measured,
side effects, especially when high doses have to be ap-and the dose- and time-dependent effects of IFNa were as-
plied. Besides milder effects such as flu-like symptomssessed. The expression patterns of junctional proteins were
examined by Western blot analysis and by confocal immuno- (nausea, fever, fatigue, myalgia, decreased concentra-
fluorescence microscopy. tion, anorexia, and chills), high doses of IFNa could
Results. IFNa produced a dose- and time-dependent de- induce critical illness through a huge range of multiorgancrease in TER. The effect was reversible on removal of IFNa
dysfunctions or a capillary leak syndrome, which mayat doses up to 5 3 103 U/ml. Tyrphostin, an inhibitor of phospho-
be life-threatening [9, 10]. One of the organs concernedtyrosine kinases, ameliorated the IFNa-induced decrease in
TER. Increased expression of occludin and E-cadherin was is the kidney, in which IFNa can induce renal dysfunction
detected by Western blot analysis after IFNa treatment. Immu- manifested by lowered glomerular filtration rate and in-
nofluorescence confocal microscopy revealed a broader stain- creased proteinuria [11, 12]. These clinical findings sug-ing of occludin and E-cadherin following IFNa treatment, with
gest that IFNa could interfere with the physiologicalprominent staining at the basal cell pole in addition to localiza-
barrier function of endothelial and possibly also epithe-tion at the junctional region. A marked increase in phosphotyr-
osine staining along the apico-lateral cell border was detected lial cells. An apparently lowered glomerular filtration
after IFNa treatment. rate may result from an increased back leak of urine
Conclusions. These findings provide evidence that IFNa can through leaky junctional complexes of proximal tubulardirectly affect barrier function in renal epithelial cells. The
epithelium. Therefore, we studied IFNa-induced changesmechanisms involve enhanced tyrosine phosphorylation and
in paracellular permeability of renal proximal tubularoverexpression and possibly displacement or missorting of the
junctional proteins occludin and E-cadherin. LLC-PK1 cells.
The tightness of an epithelium or an endothelium is
determined by intercellular junctions at the apico-lateral
Type I interferons (IFNs) are used therapeutically to cell border. The most apical of these junctions is the tight
treat several malignant or viral diseases [1–3] because junction (zonula occludens), followed by the adherens
of their ability to recruit cells of the immune system junction (zonula adherens). The tight junctions encircle
cells at their apices and represent selectively permeable
barriers between different body compartments. In addi-
Key words: tight junction, transepithelial resistance, zonula occludin,
tion to its sealing function, the tight junction plays anE-cadherin, capillary leak syndrome, urine backleak, membrane per-
meability, tyrosine. important role in polarization of epithelial cell surface
by preventing membrane lipids and proteins of the outerReceived for publication August 4, 1998
leaflet at the apical and basolateral plasma membraneand in revised form December 31, 1998
Accepted for publication January 14, 1999 domains to mix. The tight junction complex has been
described to be composed of occludin [13], a membrane- 1999 by the International Society of Nephrology
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spanning protein capable of interacting with occludin on LLC-PK1 cells after exposure to IFNa. The long-term
effects included up-regulation of Jak1. Tyrosine phos-neighboring cells by homophilic interactions [14–16] and
a number of proteins interacting with the cytoplasmic phorylation appeared to play a major role in the cellular
effects induced by IFNa in that genistein, a tyrosinedomain of occludin, namely ZO1 [17–19], ZO2 [20], cin-
gulin, and others [21, 22]. ZO-1 and ZO-2 contain several kinase inhibitor, ameliorated the effects of IFNa,
whereas vanadate, a phosphatase inhibitor, exacerbatedprotein interaction domains, for example, Src homology
3 domain, guanylate kinase-like domain, PDZ (PSD95, the IFNa-mediated effects. Protein kinase C also ap-
peared to play a role in the IFNa-mediated effects.dlg, ZO-1) domains, and proline-rich domains [18, 19],
thereby serving as a major docking site for cytoplasmic This study focused on the influence of IFNa on the
barrier function, particularly the sealing function of theproteins such as fodrin and p130, thus establishing a
direct contact between the tight junctional complex and tight junction of LLC-PK1 cells. Decreased TER on mi-
croporous substrates indicated an increased paracellularthe cytoskeletal perijunctional actin belt [23–25].
Adjacent to the tight junctions, a looser cell–cell con- permeability of the monolayer following treatment with
IFNa. Analysis of expression and intracellular distributiontact is formed by the adherens junction complex. Homo-
philic Ca21-dependent interactions between E-cadherin of tight and adherens junction proteins demonstrated dis-
turbances of intracellular positioning of the transmem-molecules on adjacent cell surfaces specify epithelial–
epithelial interactions leading to the establishment of the branous protein component of the tight and adherens
junction, namely occludin and E-cadherin. In addition,junctional belt. The cytoplasmic tail of E-cadherin inter-
acts with b-catenin or plakoglobin that link the adherens tyrosine phosphorylation was found to be increased at
the junctional belt after the addition of IFNa, suggestingjunction via a-catenin to the actin cytoskeleton [26].
Junctional complexes show differences in structure a possible involvement of tyrosine phosphorylation in
the regulation of the junctional organization by IFNa.and permeability among different types of endothelia or
epithelia. They are further able to respond to extracellu-
lar signals with changes in permeability characteristics
METHODS
[21, 27–29]. The endothelial barrier function is believed
Cell cultureto be perturbed by leukocyte adhesion and proinflam-
matory cytokines in order to allow extravasation of leu- LLC-PK1, an established epithelial cell line derived
from pig kidney cortex, was obtained from the Americankocytes [30]. In addition, several cytokines were shown
to affect epithelial cells. Insulin, insulin-like growth fac- Type Culture Collection (ATCC CRL 1392). Cells from
passages 175 to 220 were grown either on plastic culturetors, and IFNg cause an increase in paracellular perme-
ability across T84 human colonic epithelial monolayers dishes, on 30 mm tissue culture inserts (Millicell-HA-
filters; Millipore, Bedford, MA, USA), and also Anopore-[31]. Tumor necrosis factor-a (TNF-a) was shown to
influence the epithelial barrier function—leading to a filters from Nunc (Roskilde, Denmark; for monitoring
morphology by light microscopy) for TER measurement,decrease of transepithelial resistance (TER)—of renal
proximal tubular LLC-PK1 cells [32, 33] and of intestinal or on glass cover slips for immunofluorescence analysis
in Dulbecco’s modified Eagle’s medium (DMEM) con-epithelial CACO-2 BBE cells [34]. In this study, we find
similar effects on the LLC-PK1 monolayer induced by taining 1 g/liter d-glucose and 2 mm l-glutamine, supple-
mented with 10% fetal bovine serum (FCS), 100 U/mlIFNa treatment.
Interferon a has direct effects on LLC-PK1 cells (ab- penicillin, and 100 mg/ml streptomycin. TER measure-
ments were identical for both filter supports used. Thestract; Cummins et al, Ir J Med Sci 165:229, 1995), affect-
ing parameters such as morphology, viability, and trans- use of FCS facilitated the establishment of confluent
monolayers, which are necessary for TER measure-port, including dome formation and sodium-dependent
glucose transport. DNA synthesis was decreased, and ments. Anopore filters were used because of their excel-
lent translucent properties when cellular morphologyIFNa caused a blockade in the G2/M phase of the cell
cycle in proliferating, nondifferentiated cells. Confluent needed to be monitored. Cultures were fed three times
per week and were maintained in humidified 5% CO2/95%LLC-PK1 monolayers could be shown to display lower
cell numbers after IFNa treatment probably because of air atmosphere at 378C. Filter inserts were pretreated
with 1% glutaraldehyde for 10 minutes, followed by ex-necrotic cell death (abstract; Netzer et al, J Am Soc
Nephrol 5:928, 1994). Cummins et al also analyzed the tensive rinsing with sterile water and overnight incuba-
tion in FCS containing medium prior to seeding cells onintracellular signaling cascade induced by IFNa in LLC-
PK1 cells (abstract; Cummins et al, J Am Soc Nephrol filter with double seeding density. Glutaraldehyde did not
affect TER, and filters treated with glutaraldehyde gave7:1674, 1996). Similar to the IFNa action on lymphocytes
[7], activation of IFN type I receptor by IFNa in LLC- similar results to filters without glutaraldehyde treatment.
After reaching confluency, cells were preincubatedPK1 cells led to an overall increased tyrosine phosphory-
lation inside the cells. Stat1 and Stat2 were activated in with serum-free DMEM for 24 hours. Cells were treated
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with 5 3 101 to 5 3 104 IU/ml IFNa (Interferona2b, Immunofluorescence microscopy
Intron A, Aesca) in DMEM without FCS for different LLC-PK1 cells were grown on glass cover slips, washed
intervals. Serum-free medium was used during IFNa briefly with PBS, fixed with methanol, and permeabilized
treatment to prevent any possible complications from with 0.5% Triton X-100 for 20 minutes. After rinsing
growth factors in serum. The culture medium was re- with PBS and blocking with 0.5% bovine serum albumin
placed with fresh IFNa-containing medium every 12 (BSA), the cells were incubated with the antibodies for
hours and one hour before analysis to counteract IFNa one hour at 378C. Texas Red-X conjugated secondary
degradation. Control cells were fed with DMEM without antibodies (Molecular Probes, Eugene, OR, USA) were
FCS for the same intervals and with the same frequency diluted 1:50 in PBS. Indirect immunofluorescence mi-
of medium replacements. croscopy was performed either with a Zeiss Axiophot
fluorescence microscope or with a MRC-600 Lasersharp
Electrophysiological studies
system linked to a Zeiss IM 35 inverted microscope for
The sealing function of the tight junctional belt in LLC- confocal microscopy.
PK1 monolayers was assessed by measuring the TER us-
ing an EVOM volt-ohm meter (World Precision Instru- Statistical analysis
ments, New Haven, CT, USA). TER measurements were The results for TER are presented as means 6 sem
made at 378C, and TER of blank glutaraldehyde-fixed of six experiments. Statistical significance was assessed
filters was subtracted from all samples. Experimental using a nonparametric rank test for unpaired samples.
TER values were expressed as ohm 3 cm2. TER values A P of less than 0.05 was considered significant.
of freshly seeded cells were determined daily until stable
values were achieved. The experiment was initiated after
RESULTSa 24-hour preincubation with medium without FCS.
Interferon a caused a loss of epithelial tightness in
Transmission electron microscopy LLC-PK1 monolayers
Cells grown on microporous inserts (Millipore HA) Tight junction permeability was determined by mea-
were fixed with 1% glutaraldehyde, buffered with phos- suring the TER of confluent LLC-PK1 monolayers. To
phate-buffered saline (PBS), postfixed in 1% OsO4 buf- assess the influence of IFNa treatment on TER, cells
fered with Na-cacodylate (0.1 m), dehydrated in graded were incubated with different INFa concentrations for
series of ethanol, and embedded in Polybed (Polysci- up to 48 hours. Slight decreases in TER were observed
ences, Warrington, PA, USA). Ultrathin sections were after 24 hours when cell monolayers were treated with
stained conventionally by uranyl acetate and lead citrate 5 3 102 U/ml IFNa (Fig. 1A). A more pronounced effect
and were examined with a JEOL 100 C electron micro- of IFNa on TER could be observed using higher INFa
scope at 100 KV (JEOL, Tokyo Japan). concentrations (Fig. 1A). LLC-PK1 cells treated with
5 3 104 U/ml IFNa showed significant decreases in TER
Gel electrophoresis and immunoblotting versus control cells as early as 12 hours of incubation,
LLC-PK1 whole cell extracts were prepared by rinsing followed by a marked loss of epithelial tightness at later
monolayers with ice-cold PBS and scraping in lysis buffer time points (Fig. 1A). The application of IFNa to either
[50 mm Tris-HCl, 100 mm NaCl, 50 mm NaF, 40 mm the apical or the basolateral compartment alone resulted
b-glycerophosphate, 5 mm ethylenediaminetetraacetic in similar dose- and time-dependent TER decreases (Fig.
acid (EDTA) and 1% Triton X-100] containing phenyl- 1B). Incubation of the cell layer from both sides in-
methylsulfonyl fluoride (PMSF), pepstatin, leupeptin, creased the effect particularly at later time points of 24
and Na-orthovanadate. Protein content of LLC-PK1 cell hours or more (Fig. 1B). Recovery experiments were
homogenates was determined with the BCA Protein de- also carried out, and results are shown in Figure 1C. The
termination reagent (Pierce, Rockford, IL, USA), and removal of IFNa restored TER to control levels within
samples were matched with 2 3 La¨mmli-buffer. Homog- one to three days when IFNa doses between 5 3 101
enates of identical protein content were boiled for three and 5 3 103 U/ml had been applied for 48 hours (Fig.
minutes and applied to sodium dodecyl sulfate (SDS)- 1C). With the lower IFNa doses of 5 3 101 and 5 3 102
polyacrylamide gels to undergo electrophoresis. For im- U/ml, recovery of TER to control levels was complete
munoblotting, proteins were transferred from gels to an within one day. Recovery of cells treated with 5 3 103
Immobilon P (Millipore) membrane, which was incu- U/ml IFNa required a three-day period. Cells treated
bated with the first antibody after blocking with 5% with 5 3 104 U/ml IFNa for 48 hours did not recover
nonfat milk powder. Enhanced chemiluminescence Plus the TER to control levels. Inspection by light microscopy
(ECL1) Western blotting detection system and Hyper- of this group revealed very flat cells accompanied by
film (Amersham, Little Chalfont, Buckinghamshire, empty areas in the previously confluent monolayer, as
well as more free floating cells in the supernatant.UK) were used for detection.
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Fig. 1. Effect of interferon alpha (IFNa) treatment on the transepithe-
lial resistance (TER) of LLC-PK1 monolayers. (A) Concentration- and
time-dependent decrease of transepithelial resistance of LLC-PK1
monolayers treated with IFNa. LLC-PK1 cells were cultured on filter
inserts. Confluent cultures that had reached stable TER values were
preincubated in medium without FCS for 24 hours. IFNa concentration
and incubation time-dependent TER values were measured. TER val-
ues are expressed as means 6 sem of six experiments. Statistical signifi-
cant differences to controls are indicated by an asterisk. Symbols are:
(j) control; (s) 5 3 104 U/ml IFNa; (m) 5 3 102 U/ml IFNa; (e) 5 3
103 U/ml IFNa; (d) 5 3 101 U/ml IFNa. (B) Transepithelial resistance
decrease by IFNa is independent of incubation from the apical or
basolateral cell surface. Confluent cultures on filter inserts with stable
TER were treated with 5 3 103 U/ml IFNa added to the apical, basolat-
eral, or both media compartments. TER values were measured every
12 hours for 48 hours. TER values are expressed as means 6 sem
of six experiments. Statistical significant differences to controls are
indicated by an asterisk. Symbols are: (j) control; (s) 5 3 103 U/ml
IFNa apical; (m) 5 3 103 U/ml IFNa basolateral; (e) 5 3 103 U/ml
IFNa; apical and basolateral. (C) Recovery of transepithelial resistance
on removal of IFNa. After 48 hours of incubation with the indicated
concentrations of IFNa, as described in (A), cells were fed with FCS
containing medium without IFNa. Transepithelial resistance was mea-
sured for the following five days. TER values are expressed as means
6 sem of three experiments. Symbols are: (j) control; (s) 5 3 101 U/
ml IFNa; (m) 5 3 102 U/ml IFNa; (e) 5 3 103 U/ml IFNa; (d) 5 3
104 U/ml IFNa.
To analyze the specificity of IFNa action on LLC-PK1 photyrosine kinases, and we measured the TER (Fig. 2).
cells, we performed similar experiments with Madin- Tyrosine phosphorylation of key intracellular signaling
Darby canine kidney (MDCK) cells, a renal epithelial molecules has been demonstrated to transmit the signal
cell line derived from dog distal or collecting duct neph- initiated by IFNa binding to its receptor on the cell
ron [35]. Confluent MDCK cells treated with IFNa surface (abstract; Cummins et al, ibid). At a relatively
showed no changes in TER values when compared with high IFNa dose (5 3 103 U/ml), tyrphostin completely
control cells (data not shown). prevented the IFNa-induced time-dependent decrease
in TER when compared with controls (Fig. 2D). At lower
Inhibition of tyrosine phosphorylation prevented TER concentrations of IFNa (5 3 101 U/ml and 5 3 102 U/ml),
decrease after IFNa treatment tyrphostin also prevented the IFNa-induced decrease in
TER. At these concentrations and in cells not incubatedTo analyze the possible involvement of tyrosine phos-
with IFNa, tyrphostin even prevented the time-depen-phorylation in the IFNa-mediated decrease of TER, we
dent small decrease in TER normally observed in un-performed IFNa treatment of LLC-PK1 monolayers in
the presence of 100 mm tyrphostin, an inhibitor of phos- treated control cultures (Fig. 2 A, B, C).
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Fig. 2. Tyrphostin relieves the decreases of TER mediated by IFNa. Cells were incubated with IFNa, and a measurement of TER was performed
as described in Figure 1. One hundred mm tyrphostin was added to the culture medium where indicated. TER values of cells in the presence of
tyrphostin are depicted by open symbols. TER values in the absence of tyrphostin are depicted by filled symbols. Control values (without tyrphostin
and IFNa) are shown in every panel as a reference by square symbols connected by a dotted line. In (A) the symbols are: (j) control; (h)
control 1 tyrphostin. In (B) the symbols are: (d) 5 3 101 U/ml IFNa; (s) 5 3 101 U/ml IFNa 1 tyrphostin; (j) control. In (C) the symbols are:
(m) 5 3 102 U/ml IFNa; (n) 5 3 102 U/ml IFNa 1 tyrphostin; (j) control. In (D) the symbols are: (r) 5 3 103 U/ml IFNa; (s) 5 3 103 U/ml
IFNa 1 tyrphostin; (j) control. TER values are expressed as means 6 sem of four experiments. Statistically significant differences of TER of
tyrphostin-treated cells versus the control cells or cells treated with IFNa alone, respectively, are indicated by an asterisk.
Morphological changes in LLC-PK1 cells after structural changes could be detected for the architecture
interferon a treatment assessed by transmission of tight and adherens junctions.
electron microscopy
Interferon a-mediated changes in expression levels ofOnly minor changes in overall cellular morphology
the tight junctional protein occludin and the adherenswere detected by electron microscopy after treatment of
junctional protein E-cadherinLLC-PK1 monolayers with IFNa at concentrations
To unravel possible changes in the structure of tighthigher than 5 3 102 U/ml for 24 hours (Fig. 3). These
junctions and adherens junctions mediating the decreaseincluded an increased frequency of transsected vacuolar
in TER and epithelial barrier function, expression levelsstructures, enlarged cisternae of the endoplasmic reticu-
of proteins constituting tight (ZO-1, ZO-2, occludin) andlum, and a swelling of mitochondria combined with a
adherens junctions (E-cadherin, b-catenin) were mea-decreased electron density of the mitochondrial matrix.
sured by Western blot analysis. Whole cell extracts ofAn enlargement of the intercellular spaces also appeared
to occur in comparison to controls. However, no ultra- LLC-PK1 cells treated with 5 3 104 U/ml IFNa for differ-
Fig. 3. Transmission electron micrograph of LLC-PK1 cells treated with IFNa. (A, left panel) Low power electron micrograph of control LLC-PK1
monolayer grown on a Millicell HA support. Cells display a well-developed brush border (BB). Controls consistently show electron dense extracellular
staining. (A, right panel) High magnification of a junctional region showing zonula occludens and adherens. (B, left panel) Low power electron
micrograph of LLC-PK1 monolayer grown on a Millicell HA support treated with IFNa (5 3 103 U/ml for 24 hr). In contrast to controls, BB appears
“compressed,” and the apical extracellular matrix (EM) is less electron dense. (B, right panel) High magnification of a junctional region showing
zonula occludens and adherens. Abbreviations are: JC, junctional complex; TJ, tight junction; AJ, adherens junction; BB, brush border; EM, extracellular
materials; MI, mitochondrion; RI, ribosomes; ER, endoplasmatic reticulum; VA, vacuole; IC, intercellular space.
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Fig. 4. Protein expression patterns of tight and adherens junction proteins. The Western blot was performed using antibodies against occludin
(Zymed, polyclonal) and E-cadherin (Transduction Laboratories, monoclonal). Whole cell extracts from control cells and cells treated with 5 3
104 U/ml IFNa for the indicated times were compared. All cells, including control and IFNa-treated, were serum deprived for a 48-hour period.
Twenty-five micrograms of protein were loaded onto each lane. The position of molecular weight marker molecules is indicated.
ent intervals were compared with control cells. ZO-1 Using the same methodological approach, the results
with E-cadherin were similar in that IFNa increasedand ZO-2 protein levels remained unaltered (results not
shown). Occludin protein levels increased in a time- intensity of staining and led to a changed pattern with
a striking alteration of staining at the lateral cell bordersdependent manner after exposure of the cell monolayer
to IFNa (Fig. 4A). In addition to the main occludin band down to the basal cell surface (Fig. 6).
Results with ZO-1 also revealed some alteration indetected at approximately 60 kDa in LLC-PK1 cells, an
additional faster migrating band appeared when cells staining after IFNa treatment. ZO-1 is normally detected
in a continuous line with even staining along the apico-were treated with IFNa. This band may represent a
shorter occludin isoform or a post-translationally modi- lateral border of the cells (Fig. 7A). IFNa treatment
(5 3 104 U/ml for 24 hr) led to a more nodular, spottyfied occludin.
Another finding was that E-cadherin, an adherens appearance of ZO-1 along the cell border (Fig. 7B).
Confocal microscopy confirmed that this staining patternjunction protein, also showed increased protein levels
after IFNa treatment (Fig. 4B). b-Catenin expression, was confined exclusively to the junctional belt (results
not shown). No changes in intracellular distributionby contrast, remained the same in IFNa-treated and
control cells (results not shown). could be detected for ZO-2 and b-catenin (results not
shown).
Interferon a-mediated changes in the subcellular
distribution of occludin, E-cadherin, and ZO-1 Tyrosine phosphorylation concentrated at the
junctional belt after interferon a treatmentTo analyze the intracellular distribution of the tight
and adherens junction proteins under the influence of As IFNa activates intracellular tyrosine kinases via
IFNa, we performed standard or confocal immunofluo- IFNa type I receptor activation, we analyzed the possible
rescence. Confocal microscopy revealed more intense involvement of tyrosine phosphorylation in mediating
staining of occludin and E-cadherin in support of the the decrease in epithelial tightness in IFNa-treated LLC-
findings with the Western blot analysis. In Figure 5, three PK1 monolayers. To detect possible changes in cellular
horizontal cross-sections of control cells and IFNa- phosphotyrosine content and distribution, an immuno-
treated cells (Fig. 5A) were compared for staining of fluorescence analysis was performed (Fig. 8). Interest-
occludin. The pictures at the top represent the apical ingly, a marked increase in phosphotyrosine staining
side, and the picture at the bottom represents the basal along the apico-lateral cell border could be observed
side. The pattern of staining seemed to be similar in the when cells were treated with IFNa. These data show
apical plane, but differences appeared as one progressed that tyrosine phosphorylation of a junctional complex
to the basal plane. This became clearer when vertical protein, not yet identified, resulted from IFNa treatment
cross-sections of the same cells were examined (Fig. 5B). of LLC-PK1 monolayers.
In control cells, the major staining of occludin predomi-
nated at the apico-lateral junction region. In contrast,
DISCUSSIONIFNa-treated cells showed intense staining of occludin
In this study, IFNa was shown to influence the epithe-extending along the lateral cell borders down to the basal
cell surface. lial barrier function of renal proximal tubular cells, as
Fig. 5. Changes in intracellular distribution of occludin after IFNa treatment of LLC-PK1 monolayers determined by confocal immunofluorescence.
(A) LLC-PK1 cells were cultured on microscope glass cover slips. Control cells are shown in the three left panels. Cells treated with 5 3 104 U/ml
IFNa for 24 hours are shown in the right three panels. The first antibody for immunofluorescence was a polyclonal anti-occludin (Zymed). The
second was Texas Red-X conjugated anti-rabbit IgG antibody (Molecular Probes). Fluorescence was observed by confocal laser scanning microscope
(CLSM). A series of three horizontal optical cross-sections at successively lower focal levels is shown, the upper most panel representing the apical
side and the lowest panel the basal side, step size 2 mm. (B) Vertical optical cross-sections obtained by CLSM of controls or IFNa-treated cells
as in (A) are shown. The top of the panel represents the apical side, and the bottom represents the basal side.
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Fig. 5. (continued).
demonstrated by a decreased TER indicative of an in- factor 3g and bind to promoter sites of IFNa target genes
leading to gene transcription [36, 37].creased leakiness of the epithelial layer after IFNa treat-
ment. This decrease in TER supports the findings of The present data further demonstrate that despite the
known high species specific actions of cytokines, humanreduced dome formation in the LLC-PK1 cells grown on
plastic (abstract; Netzer et al, J Am Soc Nephrol 5:928, IFNa could bind to and activate pig IFN type I receptors
present on LLC-PK1 cells. Interestingly, no IFNa actions1994). These in vitro observations, if extrapolated to and
confirmed in vivo, could explain the severe and, in part, on paracellular permeability (this report) or on cellular
viability (abstract; Cummins et al, Ir J Med Sci 165:229,life-threatening adverse effects of IFNa, such as renal
dysfunction or the capillary leak syndrome. Our findings 1995) could be observed on MDCK cells. The difference
between LLC-PK1 and MDCK cells could reflect thealso support the concept of a direct effect of IFNa on
LLC-PK1 cells, as removal of IFNa from the cell culture different responsiveness of proximal and distal tubule
or collecting duct cells to IFNa. Alternatively, cross-medium showed that the induced changes in paracellular
permeability could be reversed after treatment with reaction between human IFNa and pig IFN type I recep-
tor, but not to dog type I receptor, could explain theIFNa doses up to 103 U/ml.
The decrease of TER induced by IFNa was inhibited sensitivity of LLC-PK1 but not MDCK cells to IFNa.
Differences in intracellular signaling pathways could alsoby the tyrosine kinase inhibitor tyrphostin. Cummins et
al have shown that the JAK/Stat signaling pathway is help to explain the response in LLC-PK1 cells as com-
pared with MDCK cells. For example, signal transduc-activated by IFNa in LLC-PK1 cells (abstract; J Am Soc
Nephrol 7:1674, 1996). These findings indicate that the tion by IFNa was shown to involve activation of phos-
pholipase A2, arachidonic acid, and enhanced bindingeffects of IFNa on the function of the junctional complex
are probably mediated by interaction of the cytokine of ISGF3 transcription factors in 3T3 fibroblasts when
metabolism of arachidonic acid by cyclooxygenase waswith IFN type I receptors and JAK/Stat signaling, as
tyrosine phosphorylation is crucial for signal transmis- inhibited [38]. LLC-PK1 cells have been reported to have
a defect in cyclooxygenase [39].sion. After IFNa binding, type I IFN receptor a and b
subunits dimerize, leading to the activation of cyto- An analysis of the intracellular localization of crucial
tight and adherens junction proteins by confocal immu-plasmic tyrosine kinases Jak1 and Tyk2. The tyrosine
phosphorylation of intracellular receptor domains create nofluorescence microscopy demonstrated an impaired
targeting of the transmembranous proteins of the tightdocking sites for src homology region 2 domain con-
taining signaling molecules, such as Stat1 and 2, that and adherens junction to the junctional belt, probably
resulting in impaired barrier function. Although occludinare also substrates for the activated tyrosine kinases.
Released from the receptor and imported into the cell and E-cadherin were predominantly located in the junc-
tional region in untreated monolayers, a broader stainingnucleus, Stat1 and 2 associate with IFN-stimulated gene
Fig. 6. Changes in intracellular distribution of E-cadherin after IFNa treatment of LLC-PK1 monolayers determined by confocal immunofluores-
cence. (A) LLC-PK1 cells were cultured on glass plates. Control cells are shown in the three left panels. Cells treated with 5 3 104 U/ml IFNa for
24 hours are shown in the right three panels. The first antibody for immunofluorescence was a monoclonal anti–E-cadherin antibody (Transduction
Laboratories), and the second was Texas Red-X conjugated anti mouse IgG antibody (Molecular Probes). Fluorescence was observed by confocal
laser scanning microscope (CLSM). A series of three horizontal optical cross-sections at successively lower focal levels is shown, the upper most
panel representing the apical side and the lowest panel the basal side, step size 2 mm. (B) Vertical optical cross-sections obtained by CLSM of
controls or IFNa-treated cells as in (A) are shown. The top of the panel represents the apical side, and the bottom represents the basal side.
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Fig. 6. (Continued).
Fig. 7. Changes in the ZO-1 staining pattern after IFNa treatment. LLC-PK1 cells were cultured on glass plates. Confluent monolayers were used
as controls (A) or treated with 5 3 104 U/ml IFNa for 24 hours (B). The anti-ZO1 antibody used for immunofluorescence was from Chemicon,
and the second was a Texas Red-X conjugated antirat IgG antibody from Molecular Probes. The laser scanning microscope was used in the
standard immunofluorescence mode (nonconfocal).
pattern was observed in IFNa-treated cells, indicating along the basolateral membrane preceding tight junc-
tional localization [40]. These findings could thereforelocalization of the proteins along the entire basolateral
membrane surface concentrating in vesicular structures indicate a disturbance of the final assembly of occludin
and possibly also E-cadherin into the junctional complexat the basal cell pole. In a recent report, basolateral
targeting was shown to be mediated by the C-terminal by IFNa treatment. In addition, relative protein amounts
of occludin and E-cadherin were increased in IFNa-domain of occludin, leading to incorporation of occludin
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Fig. 8. A phosphotyrosine containing protein is concentrated at the junctional belt after IFNa treatment of LLC-PK1 cells. LLC-PK1 cells were
cultured on glass plates. Confluent monolayers were used as controls (A) or treated with 5 3 104 U/ml IFNa for 24 hours (B). The antiphosphotyrosine
antibody used for standard immunofluorescence was a polyclonal antibody from Transduction Laboratories, and the second was a Texas Red-X
conjugated antirabbit IgG antibody (Molecular Probes).
treated cells. Interestingly, Balkovetz, Pollack, and Mos- polymerization to produce stress fibers and lamellipodia,
respectively [43, 44]. In epithelial cells, Rho and Ractov found similar rearrangements and increased expres-
sion of E-cadherin when MDCK cells were treated with have been shown to be involved in the regulation of
cadherin-mediated cell–cell adhesion [45], indicating ahepatocyte growth factor (HGF), and concluded that
HGF treatment of polarized MDCK decreases cell polar- Rho/Rac dependent pathway as a potential signaling
mechanism controlling junctional complex organizationity and alters E-cadherin/b-catenin interaction and syn-
thesis [41]. In a review of cell polarity by Drubin and and function.
The increase of the relative protein amount of E-cad-Nelson, dislocations of junctional proteins similar to
those observed in this study under the influence of IFNa herin and occludin observed under the influence of IFNa
could be the consequence of altered gene expression regu-have been discussed [42]. The rearrangements seem to
be controlled by the small GTPase proteins Rho and lation mediated by an IFNa-induced signaling network.
High expression of E-cadherin has been shown to interfereRac and also to correlate with an increased paracellular
permeability. In fibroblasts, Rho and Rac regulate actin with cancer progression [46]. In this way, up-regulation
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